Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
The company expects the full year's revenue to be around $1.05 billion, close to analysts' estimates. Its non-GAAP loss of $1.25 per share was 10.5% below analysts' consensus estimates. Is now the time to buy Novavax? Find out in our full research report Revenue: $70.45 million vs analyst estimates of $43.75 million (16.6% year-on-year decline, 61% beat) Adjusted EPS: -$1.25 vs analyst expectations of -$1.13 (10.5% miss) Adjusted EBITDA: -$171.4 million (-243% margin, 41.3% year-on-year decline) Operating Margin: -253%, down from -159% in the same quarter last year Free Cash Flow was $105.8 million, up from -$146.8 million in the same quarter last year Market Capitalization: $1.09 billion Pioneering a nanoparticle technology that mimics the molecular structure of disease pathogens, Novavax (NASDAQ:NVAX) develops and commercializes protein-based vaccines for infectious diseases, with a primary focus on its COVID-19 vaccine and combination respiratory vaccine candidates.
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 1/12/26 - Form 8-K
- 12/15/25 - Form 4
- 11/12/25 - Form SCHEDULE
- NVAX's page on the SEC website